• US: +1 9176726599
  • Login

Plasma Derived Medicine Market Is Expected to Grow At 7.1% CAGR during the Forecast Period

Published date - 10/03/2023

March 2022 | Report Format: Electronic (PDF)

The advancement and development of better methods for preserving these blood plasma derivatives, as well as newer and developed fractionation procedures, are driving the global blood plasma derivatives market's growth. Furthermore, the rising prevalence of life-threatening diseases like HIV, hepatitis, and haemophilia creates demand and opportunity in the global blood plasma derivatives market. Furthermore, various government and non-governmental organization initiatives to conduct and promote blood donation camps have resulted in an increase in human blood collection. This is fuelling the growth of the global blood plasma derivatives market.

 Request a Free Sample Copy: Plasma Derived Medicine Market Report

Plasma Derived Medicine Market Report Highlights

  • In November 2021, Kamada Pharmaceuticals, a global specialty plasma-derived biopharmaceutical company, announced that it had acquired a portfolio of four plasma-derived hyperimmune commercial products approved by the U.S. Food and Drug Administration (FDA) from Saol Therapeutics, a commercial specialty pharmaceutical company focused on addressing the medical needs of unserved or underserved patient populations.
  • In March 2020, Grifols, S.A., a multinational pharmaceutical and chemical manufacturer, announced a collaboration with the U.S. Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA), and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this specific plasma, and conduct the necessary preclinical and clinical studies to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can be used successfully to treat the COVID-19.

PLASMA-DERIVED MEDICINE MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Plasma Derived Medicine Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Albumin
  • Coagulation Factors
  • Immunoglobulins
  • Others

Plasma Derived Medicine Indication Outlook (Revenue, USD Million, 2016 - 2027)

  • Pelvic Inflammatory Disease (IPD)
  • Bleeding Disorders
  • Alpha-1 Antitrypsin Deficiency (AATD)
  • Hereditary Angioedema (HAE)
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Guillain-Barre Syndrome
  • Multifocal Motor Neuropathy
  • Liver Diseases
  • Primary Immune Thrombocytopenia
  • Infections
  • Other Orphan Diseases

Plasma Derived Medicine Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Plasma Derived Medicine Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
  • Central & South America
    • Brazil
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa

List of Key Players- Plasma Derived Medicine Market

  • Grifols, S.A
  • SK Plasma
  • Fusion Healthcare
  • Takeda
  • LFB
  • Octapharma AG
  • CSL Limited
  • Bio Products Laboratory
  • China Biologic Products Holdings
  • Kedrion
  • Shanghai RAAS
  • ADMA Biologics
  • Kameda Pharmaceuticals
  • Biotest AG

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

473 Mundet Place,

Ste US520501 Hillside

New Jersey 07205 United States

USA Phone: ++1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/

Copyright © 2022 Market Research Strategy, All rights reserved.